Abed Agbarya

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Topics

Patients Undergoing

Epidermal Growth Factor Receptor

Papillary Thyroid

Top Venues

Journal of clinical medicine

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Sanaa Musa, Noor Amara, Adan Selawi, Junbiao Wang, Cristina Marchini, Abed Agbarya, Jamal Mahajna
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib. Cancers 16 (13) (2024)
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current oncology (Toronto, Ont.) 31 (8) (2024)
Urska Janzic, Andrej Janzic, Abed Agbarya, Urska Bidovec-Stojkovic, Katja Mohorcic, Marina Caks, Peter Korosec, Matija Rijavec, Erik Skof
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes. Biomedicines 12 (3) (2024)
Dan Levy Faber, Abed Agbarya, Ben Caspy, Moshe Lapidot, Shoshana Keren Rosenberg, Sonia Schneer, Erez Sharoni, Ronen Galili
A Single-Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Diseases (Basel, Switzerland) 12 (5) (2024)
Dan Levy Faber, Abed Agbarya, Ben Caspy, Moshe Lapidot, Shoshana Keren Rosenberg, Sonia Schneer, Erez Sharoni, Ronen Galili
A Single-Center Experience in Combined Oncological-Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC). Diseases (Basel, Switzerland) 12 (5) (2024)
Sanaa Musa, Noor Amara, Adan Selawi, Junbiao Wang, Cristina Marchini, Abed Agbarya, Jamal Mahajna
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib. Cancers 16 (13) (2024)
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current oncology (Toronto, Ont.) 31 (8) (2024)
Urska Janzic, Natalie Maimon Rabinovich, Walid Shalata, Waleed Kian, Katarzyna Szymczak, Rafal Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani Charpidou, Sameh Daher, Abed Agbarya
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study). Current oncology (Toronto, Ont.) 31 (8) (2024)
Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, Alexander Yakobson, Yulia Dudnik, Ashraf Abu Jama, Ahron Yehonatan Cohen, Sondos Shalata, Ahmad Abu Hamed, Tahel Ilan Ber, Oshri Machluf, Gal Shoham Levin, Amichay Meirovitz
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status. Cancers 16 (10) (2024)
Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, Alexander Yakobson, Yulia Dudnik, Ashraf Abu Jama, Ahron Yehonatan Cohen, Sondos Shalata, Ahmad Abu Hamed, Tahel Ilan Ber, Oshri Machluf, Gal Shoham Levin, Amichay Meirovitz
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status. Cancers 16 (10) (2024)
Urska Janzic, Andrej Janzic, Abed Agbarya, Urska Bidovec-Stojkovic, Katja Mohorcic, Marina Caks, Peter Korosec, Matija Rijavec, Erik Skof
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes. Biomedicines 12 (3) (2024)
Mohammad Sheikh-Ahmad, Yara Shalata, Jacob Bejar, Hila Kreizman Shefer, Majd F Sirhan, Monica Laniado, Ibrahim Matter, Abed Agbarya, Maria Reut, Ekaterina Yovanovich, Leonard Saiegh
The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Abed Agbarya, Ina Sarel, Tomer Ziv-Baran, Orna Schwartz, Yelena Shechtman, Ella Kozlener, Rasha Khoury, Mohammad Sheikh-Ahmad, Leonard Saiegh, Forat Swaid, Asala Abu Ahmad, Urska Janzic, Ronen Brenner
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments. Diseases (Basel, Switzerland) 11 (4) (2023)
Urska Janzic, Walid Shalata, Katarzyna Szymczak, Rafał Dziadziuszko, Marko Jakopovic, Giannis S Mountzios, Adam Płużański, Antonio Araujo, Andriani G Charpidou, Abed Agbarya
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations. International journal of molecular sciences 24 (16) (2023)
Walid Shalata, Alexander Yakobson, Yulia Dudnik, Forat Swaid, Mohammad Sheikh Ahmad, Ashraf Abu Jama, Ahron Yehonatan Cohen, Abed Agbarya
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer. Biomedicines 11 (9) (2023)
Mohammad Sheikh-Ahmad, Leonard Saiegh, Anan Shalata, Jacob Bejar, Hila Kreizman-Shefer, Majd F Sirhan, Ibrahim Matter, Forat Swaid, Monica Laniado, Nama Mubariki, Tova Rainis, Ilana Rosenblatt, Ekaterina Yovanovich, Abed Agbarya
Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study. Biomedicines 11 (3) (2023)
Walid Shalata, Ashraf Abu Jama, Amjad Abu Salman, Mitchell Golosky, Adam Solomon, Omar Abu Saleh, Regina Michlin, Sondos Shalata, Abed Agbarya, Alexander Yakobson
Unexpected and Rare Sites of Metastasis in Oncologic Patients. Journal of clinical medicine 12 (20) (2023)
Mohammad Sheikh-Ahmad, Yara Shalata, Jacob Bejar, Hila Kreizman Shefer, Majd F Sirhan, Monica Laniado, Ibrahim Matter, Abed Agbarya, Maria Reut, Ekaterina Yovanovich, Leonard Saiegh
The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Mohammad Sheikh-Ahmad, Leonard Saiegh, Anan Shalata, Jacob Bejar, Hila Kreizman-Shefer, Majd F Sirhan, Ibrahim Matter, Forat Swaid, Monica Laniado, Nama Mubariki, Tova Rainis, Ilana Rosenblatt, Ekaterina Yovanovich, Abed Agbarya
Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study. Biomedicines 11 (3) (2023)
Mohammad Sheikh-Ahmad, Yara Shalata, Jacob Bejar, Hila Kreizman Shefer, Majd F Sirhan, Monica Laniado, Ibrahim Matter, Abed Agbarya, Maria Reut, Ekaterina Yovanovich, Leonard Saiegh
The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Mohammad Sheikh-Ahmad, Yara Shalata, Jacob Bejar, Hila Kreizman Shefer, Majd F Sirhan, Monica Laniado, Ibrahim Matter, Abed Agbarya, Maria Reut, Ekaterina Yovanovich, Leonard Saiegh
The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness. Medicina (Kaunas, Lithuania) 59 (1) (2023)
Eran Ben-Arye, Dorit Gamus, Noah Samuels, Elad Schiff, David Hausner, Orit Gressel, Samuel Attias, Ofer Lavie, Adi David, Katerina Shulman, Abed Agbarya
Acupuncture and integrative oncology for taxane-induced peripheral neuropathy: a randomized multicentered study. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)
Ari Raphael, Elizabeth Dudnik, Dov Hershkovitz, Suyog Jain, Steven Olsen, Lior Soussan-Gutman, Taly Ben-Shitrit, Addie Dvir, Hovav Nechushtan, Nir Peled, Amir Onn, Abed Agbarya, null On Behalf Of The Israel Lung Cancer Group
FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC). Journal of clinical medicine 11 (9) (2022)
Abed Agbarya, Walid Shalata, Alfredo Addeo, Andriani G Charpidou, Kristof Cuppens, Odd Terje Brustugun, Mirjana Rajer, Marco Jakopovic, Mihai Vasile Marinca, Adam Pluzanski, Thijo Jeroen N Hiltermann, Antonio Araujo
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment. Journal of clinical medicine 11 (6) (2022)
Walid Shalata, Alexander Yakobson, Rachel Steckbeck, Ashraf Abu Jama, Omar Abu Saleh, Abed Agbarya
Is Elevation of Alkaline Phosphatase a Predictive Factor of Response to Alectinib in NSCLC? Current oncology (Toronto, Ont.) 29 (1) (2021)
Walid Shalata, Binil Mathew Jacob, Abed Agbarya
Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future. Cancers 13 (16) (2021)
Abed Agbarya, Ina Sarel, Tomer Ziv-Baran, Sivan Agranat, Orna Schwartz, Ayelet Shai, Sharon Nordheimer, Shlomit Fenig, Yelena Shechtman, Ella Kozlener, Tarek Taha, Haitam Nasrallah, Roma Parikh, Nadav Elkoshi, Carmit Levy, Rasha Khoury, Ronen Brenner
Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs. Cancers 13 (16) (2021)
Chun Ho Szeto, Walid Shalata, Alexander Yakobson, Abed Agbarya
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future. Journal of clinical medicine 10 (23) (2021)
Tarek Taha, Rasha Khoury, Ronen Brenner, Haitam Nasrallah, Irena Shofaniyeh, Samih Yousef, Abed Agbarya
Treatment of Rare Mutations in Patients with Lung Cancer. Biomedicines 9 (5) (2021)
Miguel Gorenberg, Abed Agbarya, David Groshar, Ilya Volovik, Ofir Avitan, Igor Sukhotnik
Novel nanotech antioxidant cocktail prevents medical diagnostic procedures ionizing radiation effects. Scientific reports 11 (1) (2021)
Nicola J Nasser, Miguel Gorenberg, Abed Agbarya
First line Immunotherapy for Non-Small Cell Lung Cancer. Pharmaceuticals (Basel, Switzerland) 13 (11) (2020)